Area under the plasma concentration-time curve of inorganic fluoride following sevoflurane anesthesia correlates with CYP2E1 mRNA level in mononuclear cells

Anesthesiology

Volumn 92, Issue 6, 2000, Pages 1661-1666

  Hase, Ichiro ^c   Imaoka, Susumu ^c   Oda, Yutaka ^b   Hiroi, Toyoko ^c   Nakamoto, Tatsuo ^a   Asada, Akira ^c   Funae, Yoshihiko ^c  

^a Osaka City Kita Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Competitive RT PCR; CYP2E1; Mononuclear cells; Sevoflurane

Indexed keywords

CYTOCHROME P450; MESSENGER RNA; SEVOFLURANE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; GENERAL ANESTHESIA; HUMAN; HUMAN CELL; MALE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0034046029     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200006000-00025     Document Type: Article

References (17)

1. Frink EJ Jr, Malan TP Jr, Isner RJ, Brown EA, Morgan SE, Brown BR Jr: Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. ANESTHESIOLOGY 1994; 80:1019-25
2. Kharasch ED, Thummel KE: Identification of cytochrome P4502E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. ANESTHESIOLOGY 1993; 79:795-807
3. Wandel C, Neff S, Keppler G, Bohrer H, Stockinger K, Wilkinson GR, Wood M, Martin E: The relationship between cytochrome P4502E1 activity and plasma fluoride levels after sevoflurane anesthesia in humans. Anesth Analg 1997; 85:924-30
4. Kharasch ED, Karol MD, Lanni C, Sawchuk R: Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. ANESTHESIOLOGY 1995; 82:1369-78
5. Lieber CS: Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 1997; 77:517-44
6. Andersen MR, Farin FM, Omiecinski CJ: Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR. DNA Cell Biol 1998; 17:231-8
7. Heuvel JPV, Clark GC, Thompson CL, McCoy Z, Miller CR, Lucier GW, Bell DA: CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 1993; 14:2003-6
8. Raucy JL, Curley G, Carpenter SP: Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P4502E1. Alcohol Clin Exp Res 1995; 19:1369-75
9. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, Carpenter SP: Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 1997; 25:1429-35
10. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230:1350-4
11. Katoh T, Ikeda K: The minimum alveolar concentration (MAC) of sevoflurane in humans. ANESTHESIOLOGY 1987; 66:301-3
12. Zimmermann K, Mannhalter JW: Technical aspects of quantitative competitive PCR. Biotechniques 1996; 21:268-79
13. Watanabe J, Hayashi S, Kawajiri K: Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 1994; 116:321-6
14. Ponte P, Ng SY, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687-96
15. Kharasch ED, Thummel KE, Mhyre J, Lillibridge JH: Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1. Clin Pharmacol Ther 1993; 53:643-50
16. Malan TP Jr, Sameshima T, Mata H, Frink EJ Jr: Relationship of inspired anesthetic concentration to plasma concentration and urinary excretion of sevoflurane metabolites in rats. Anesth Analg 1995; 81: 576-80
17. Eliasson E, Johansson I, Ingelman-Sundberg M: Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation. Proc Natl Acad Sci U S A 1990; 87:3225-9